Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1
NCT04393753
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Merkel Cell Carcinoma
Interventions
DRUG:
domatinostat in combination with avelumab
Sponsor
4SC AG